StockDrifts LogoStockDrifts

Wakamoto Pharmaceutical Co.,Ltd. 4512

Company
わかもと製薬株式会社Wakamoto Pharmaceutical Co.,Ltd.
Investors
5
Buys
8
Total Value
¥1.5B ($9.9M)
Avg Return
+14.65%
Last Filing
2026-01-09

Wakamoto Pharmaceutical Co.,Ltd. (4512) has 8 disclosed large-shareholding filings and 4 disclosed disposals on record, filed by 5 distinct investors. Together those filings cover ¥1.5B ($9.9M) in reported transaction value. The earliest filing StockDrifts holds for Wakamoto Pharmaceutical Co.,Ltd. is dated 2021-03-22; the most recent is 2026-01-09. Across these filings the average return since disclosure is +14.65%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

DateTypeSourceInsiderPurposeSharesPrice at filingReturnValue
2026-08-27BUYMarket Buy
アセット・バリュー・インベスターズ・リミテッド (Asset Value Investors Limited)
Asset Value Investors Limited
activist4.1M¥308-3.9%¥112M ($720K)
2026-01-09BUYMarket Buy
アセット・バリュー・インベスターズ・リミテッド (Asset Value Investors Limited)
Asset Value Investors Limited
activist3.7M¥299-1.0%¥106M ($685K)
2025-05-29BUYMarket Buy
アセット・バリュー・インベスターズ・リミテッド (Asset Value Investors Limited)
Asset Value Investors Limited
activist3.3M¥293+1.0%¥106M ($685K)
2025-04-01BUYMarket Buy
アセット・バリュー・インベスターズ・リミテッド (Asset Value Investors Limited)
Asset Value Investors Limited
activist3.0M¥312-5.1%¥118M ($764K)
2025-03-07BUYMarket Buy
アセット・バリュー・インベスターズ・リミテッド (Asset Value Investors Limited)
Asset Value Investors Limited
activist2.6M¥286+3.5%¥131M ($842K)
2025-02-27BUYMarket Buy
アセット・バリュー・インベスターズ・リミテッド (Asset Value Investors Limited)
Asset Value Investors Limited
activist2.1M¥282+5.0%¥603M ($3.9M)
2025-02-13BUYunknown
ロート製薬株式会社
ROHTO PHARMACEUTICAL CO.,LTD.
other4.0M¥250+18.4%¥993M ($6.4M)
2021-11-08BUYunknown
株式会社みずほ銀行
Mizuho Bank, Ltd.
strategic1.1M¥317--
2021-11-08SELLunknown
みずほ証券 株式会社
Mizuho Securities Co., Ltd.
other1.3K¥317+6.6%¥62M ($399K)
2021-11-08SELLunknown
アセットマネジメントOne株式会社
Asset Management One Co., Ltd.
other500.6K¥317+6.6%¥13M ($85K)
2021-06-07BUYunknown
株式会社みずほ銀行
Mizuho Bank, Ltd.
strategic1.1M¥338--
2021-06-07SELLunknown
みずほ証券 株式会社
Mizuho Securities Co., Ltd.
other193.6K¥338+12.4%¥183M ($1.2M)
2021-06-07BUYunknown
アセットマネジメントOne株式会社
Asset Management One Co., Ltd.
other543.0K¥338-12.4%¥7M ($46K)
2021-03-22BUYunknown
株式会社みずほ銀行
Mizuho Bank, Ltd.
strategic1.1M¥728.073--
2021-03-22BUYunknown
みずほ証券 株式会社
Mizuho Securities Co., Ltd.
other735.0K¥728.073-59.3%¥421M ($2.7M)
2021-03-22SELLunknown
アセットマネジメントOne株式会社
Asset Management One Co., Ltd.
other521.2K¥728.073+59.3%¥79M ($507K)

Frequently asked questions

Who has been buying Wakamoto Pharmaceutical Co.,Ltd. stock?
5 distinct investors have filed 8 disclosed large-shareholding filings in Wakamoto Pharmaceutical Co.,Ltd. (4512), most recently on 2026-01-09. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Wakamoto Pharmaceutical Co.,Ltd. have?
Wakamoto Pharmaceutical Co.,Ltd. has 8 buy-side and 4 sell-side disclosures on record, covering ¥1.5B ($9.9M) in total reported value, spanning 2021-03-22 to 2026-01-09.
Do insider buys in Japanese stocks predict returns?
Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.